RBM7 Subunit of the NEXT Complex Binds U-Rich Sequences and Targets

RBM7 Subunit of the NEXT Complex Binds U-Rich Sequences and Targets

4236–4248 Nucleic Acids Research, 2015, Vol. 43, No. 8 Published online 6 April 2015 doi: 10.1093/nar/gkv240 RBM7 subunit of the NEXT complex binds U-rich sequences and targets 3-end extended forms of snRNAs Dominika Hrossova1,2, Tomas Sikorsky1,2, David Potesil1, Marek Bartosovic1,2, Josef Pasulka1, Zbynek Zdrahal1, Richard Stefl1,2,* and Stepanka Vanacova1,* 1CEITEC–Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic and 2National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno, 62500, Czech Republic Downloaded from https://academic.oup.com/nar/article/43/8/4236/2414277 by guest on 01 October 2021 Received October 15, 2014; Revised March 05, 2015; Accepted March 06, 2015 ABSTRACT budding yeast are the Trf4/5-Air1/2-Mtr4 Polyadenylating (TRAMP) and Nrd1-Nab3-Sen1 (NNS) complexes (3–6). The Nuclear Exosome Targeting (NEXT) complex The TRAMP is composed of the non-canonical poly(A)- is a key cofactor of the mammalian nuclear exo- polymerase (PAP) Trf4p or Trf5p, the zinc-knuckle (ZnK) some in the removal of Promoter Upstream Tran- protein Air1p or Air2p and the RNA helicase Mtr4p (4– scripts (PROMPTs) and potentially aberrant forms of 7). TRAMP adds untemplated oligo(A) tail to the 3 end of other noncoding RNAs, such as snRNAs. NEXT is the RNA substrate which serves as a landing platform for composed of three subunits SKIV2L2, ZCCHC8 and the exosome. The NNS is formed by two RNA-binding pro- RBM7. We have recently identified the NEXT complex teins Nrd1p and Nab3p and an RNA helicase Sen1p (8). It in our screen for oligo(U) RNA-binding factors. Here, is believed, that the NNS complex has a central role in RNA we demonstrate that NEXT displays preference for polymerase II (RNAP II) transcription termination of non- U-rich pyrimidine sequences and this RNA binding coding RNAs such as cryptic unstable transcripts (CUTs), or sn/snoRNAs (9–11). The NNS complex directly inter- is mediated by the RNA recognition motif (RRM) of acts with the terminator motifs in the nascent transcript as the RBM7 subunit. We solved the structure of RBM7 well as with the RNAPII via its C-terminal domain (CTD) RRM and identified two phenylalanine residues that (8,12–14). Subsequently, after termination the NNS com- are critical for interaction with RNA. Furthermore, we plex interacts with the TRAMP-exosome and mediates 3 showed that these residues are required for the NEXT end trimming and maturation or complete degradation of a interaction with snRNAs in vivo. Finally, we show that substrate (3,11,15). depletion of components of the NEXT complex alone Two TRAMP-like exosome cofactors have been iden- or together with exosome nucleases resulted in the tified in mammalian cells; the human TRAMP complex accumulation of mature as well as extended forms of and the Nuclear Exosome Targeting (NEXT) complex snRNAs. Thus, our data suggest a new scenario in (16). Surprisingly, regardless of the presence of the hu- which the NEXT complex is involved in the surveil- man Sen1p homolog––Senataxin, attempts to identify ho- mologs of Nrd1 and Nab3 were so far unsuccessful. How- lance of snRNAs and/or biogenesis of snRNPs. ever, despite the lack of any sequence homology, the human CBCA complex (cap-binding complex (CBC) interacting INTRODUCTION with ARS2) shows functional analogy with the yeast NNS (17,18). CBCA physically interacts with the NEXT com- The recent expansion of transcriptome-wide screens led plex forming a CBCN complex, which promotes transcrip- to the identification of the complexity of the eukaryotic tion termination at snRNA loci, and in promoter-upstream non-coding RNAome. The processing and stability of these regions expressing PROMPTs (17,19). However, the down- RNAs undergoes strict monitoring by RNA surveillance regulation of NEXT components did not result in RNA machines. In yeast, one of the key factors in these pro- Polymerase II termination defects on snRNA genes and cesses is a conserved ten to eleven-subunit protein com- PROMPTS, respectively, suggesting that NEXT may play plex with 3-5 exoribonuclease activity, called the exo- a different role in ncRNA biology (17). some (1,2). Several cofactors direct the exosome to spe- cific RNA targets. The most prominent nuclear cofactors in *To whom correspondence should be addressed. Tel: +420 549495042; Email: [email protected] Correspondence may also be addressed to Richard Stefl. Tel: +420 549492436; Fax: +420 549492556; Email: [email protected] C The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Research, 2015, Vol. 43, No. 8 4237 The NEXT complex is composed of hMTR4 (SKIV2L2), To remove unspecific binders, the protein extracts were zinc knuckle protein ZCCHC8 and RNA binding pro- first pre-cleared using 100 ␮l of packed Streptavidin agarose tein RBM7 (16,20). Apart from NEXT involvement in (SAg) resin (Thermo Scientific), washed twice with Low salt PROMPT turnover, several lines of evidence have linked buffer (LSB) (20 mM HEPES pH 8.0, 100 mM KCl, 10 NEXT to spliceosomes. All three subunits have been ini- mM MgCl2, 0.01% NP40, 1 mM DTT). Fresh SAg was tially co-purified with spliceosomes in a large-scale pro- pre-blocked in blocking buffer (LSB containing 1 ␮g/ml teomics screen (21). RBM7 was shown to interact with RNase-free BSA, 20 ␮g glycogen, 50 ␮g yeast total RNA) two essential splicing factors, SAP145 and SRp20 (22)and for 1 h at 4◦C with slow rotation. One milliliter of block- SKIV2L2 with U4/U6.U5 tri-snRNP-associated proteins ing per 100 ␮l of packed SAg beads buffer was used. SAg (23). Moreover, the RBM7 subunit has been recently shown were then washed twice with High salt buffer (HSB) (20 mM to target U1 and U2 snRNAs (17). HEPES pH 8.0, 300 mM KCl, 10 mM MgCl2, 0.01% NP40, Our previous work identified all three components of the 1 mM DTT) and stored as 1:1 slurry (SAg beads : HSB). NEXT complex specifically co-precipitated with U RNA To prepare SAg-RNA matrix, 40 ␮l of pre-blocked slurry 30 Downloaded from https://academic.oup.com/nar/article/43/8/4236/2414277 by guest on 01 October 2021 (24). In this work, we characterize the RNA-binding and of SAg beads was mixed with 5 volumes of HSB contain- structural properties of the RBM7 subunit. We demon- ing 10 ␮g biotinylated U30 RNA oligo (Sigma) and 50U of strate the RBM7 preference for U-rich pyrimidine motifs. RNasin Plus RNase inhibitor (Promega) in HSB. The mix- We present the solution structure of RBM7 RRM and map ture was incubated for 5 h at 4◦C with rotation. SAg beads the residues involved in RNA binding. Moreover, we show were collected by 1 min centrifugation at 1500g and washed that this RNA binding mode is important for targeting dif- three times with 1 ml of HSB. For protein precipitation, 150 ferent forms of snRNAs in vivo and propose the role of ␮l of pre-cleared protein extract was added and incubated NEXT in metabolism of snRNAs. for 1 h at 30◦C with rotation. SAg beads were briefly col- lected by centrifugation at 1500g and washed three times ␮ MATERIALS AND METHODS with 1 ml of HSB. Bound proteins were eluted with 20 l of 1x SDS loading buffer. Proteins were separated on 12% Cell culture and manipulation polyacrylamide gels and silver stained. Mammalian cells (HEK293T-Rex, HeLa) were maintained in Dulbecco’s modified Eagle’s medium supplemented with Analysis of proteins by mass spectrometry 10% fetal calf serum at 37◦C in the presence of 5% CO2. For transient transfections, cells were grown to 70% confluency, Protein samples were processed by filter-aided sample and plasmid DNA was transfected using TURBOFECT preparation (FASP) method (25,26). Proteins were alky- (Fermentas) following the manufacturer’s instructions. lated, digested by trypsin on filter unit membrane and re- sulting peptides were eluted by ammonium bicarbonate. Peptide mixture was dried under vacuum and transferred Protein extracts preparation and cell fractionation using peptide extraction procedure to LC-MS vial contain- HEK293 cells were washed, re-suspended in buffer contain- ing PEG (27). Peptides were injected to LC-MS/MS system ing 10 mM HEPES pH 7.9, 1.5 mM MgCl2,10mMKCl, (RSLCnano connected to Orbitrap Elite; Thermo Fisher 2 mM DTT and 0.2 mM PMSF and incubated 10 min on Scientific, Waltham, MA, USA) after concentration un- ice. Cells were broken in a Dounce homogenizer and nuclei der vacuum. MS data were acquired in a data-dependent were pelleted by centrifugation at 400 g for 15 min at 4◦C. strategy selecting up to top 20 precursors based on precur- The supernatant represented the cytoplasmic fraction. Nu- sor abundance in the survey scan (350–1700 m/z). Low- clear pellet was then incubated with buffer containing 20 resolution CID MS/MS spectra were acquired in ion trap. mM HEPES pH 7.9, 25% glycerol, 20 mM KCl, 1.5 mM The analysis of the mass spectrometric RAW data files MgCl2, 0.2 mM EDTA, 2 mM DTT and 0.2 mM PMSF. was carried out using the Proteome Discoverer software Next, the concentration of KCl was increased up to 1.2 M (Thermo Fisher Scientific; version 1.3) with in-house Mas- and extracts were incubated for additional 30 min at 4◦C.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    13 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us